SENS

Senseonics Holdings Inc

Jan 29 • 04:00PM ET

6.96

+0.14 2.05 %

Healthcare • Medical Devices • USA • NASD

Jan 29, 4:05 PMSenseonics announces it has received CE Mark approval for its year-long Eversense 365 continuous glucose monitoring system, clearing the way for commercialization in the European Union with launches planned in Germany, Italy, Spain and Sweden in the coming months.

Peers: DXCM ABT TNDM PODD MDT LIVN HOLX BSX SYK BAX

| Held by: VTI VXF SCHA ITOT SCHB DFAC FDHT DFUS DCOR DFAU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.71	Insider Own	10.76%	Shs Outstand	40.81M	Perf Week	-7.32%
Market Cap	284.37M	Forward P/E	-	EPS next Y	-2.41	Insider Trans	0.70%	Shs Float	36.46M	Perf Month	22.75%
Enterprise Value	214.26M	PEG	-	EPS next Q	-0.43	Inst Own	15.42%	Short Float	11.12%	Perf Quarter	-3.33%
Income	-63.77M	P/S	9.71	EPS this Y	39.03%	Inst Trans	7.30%	Short Ratio	9.34	Perf Half Y	-28.98%
Sales	29.30M	P/B	3.63	EPS next Y	-64.84%	ROA	-53.98%	Short Interest	4.05M	Perf YTD	26.09%
Book/sh	1.92	P/C	2.56	EPS next 5Y	3.78%	ROE	-129.29%	52W High	28.00 -75.14%	Perf Year	-68.65%
Cash/sh	2.72	P/FCF	-	EPS past 3/5Y	44.14% 27.24%	ROIC	-53.65%	52W Low	5.25 32.57%	Perf 3Y	-68.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	18.01% 1.08%	Gross Margin	41.11%	Volatility	6.31% 6.97%	Perf 5Y	-84.94%
Dividend TTM	-	EV/Sales	7.31	EPS Y/Y TTM	36.59%	Oper. Margin	-210.54%	ATR (14)	0.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.93	Sales Y/Y TTM	31.94%	Profit Margin	-217.65%	RSI (14)	51.23	Recom	2.12
Dividend Gr. 3/5Y	- -	Current Ratio	6.23	EPS Q/Q	43.76%	SMA20	0.50%	Beta	1.00	Target Price	18.92
Payout	-	Debt/Eq	0.53	Sales Q/Q	89.89%	SMA50	7.34%	Rel Volume	1.03	Prev Close	6.82
Employees	117	LT Debt/Eq	0.52	Earnings	Nov 05 AMC	SMA200	-23.20%	Avg Volume	434.08K	Price	6.96
IPO	Dec 22, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.85% 1.34%	Trades		Volume	449,725	Change	2.05%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Resumed	Stifel	Hold	$9
Aug-27-25	Initiated	Barclays	Overweight	$1.50
Jul-15-25	Initiated	TD Cowen	Buy	$1.25
Jun-02-25	Resumed	H.C. Wainwright	Buy	$1.10
Apr-10-25	Initiated	Mizuho	Outperform	$2
Jul-19-23	Initiated	Jefferies	Underperform	$0.50
Aug-19-21	Initiated	H.C. Wainwright	Buy	$6
Apr-01-21	Downgrade	SVB Leerink	Outperform → Mkt Perform	$3
Mar-05-21	Downgrade	Raymond James	Mkt Perform → Underperform
Jan-21-21	Downgrade	BTIG Research	Buy → Neutral
Jan-20-21	Downgrade	Craig Hallum	Hold → Sell
Aug-11-20	Upgrade	Craig Hallum	Sell → Hold
Aug-11-20	Upgrade	BTIG Research	Neutral → Buy	$1
Mar-13-20	Downgrade	Guggenheim	Buy → Neutral
Mar-13-20	Downgrade	BTIG Research	Buy → Neutral
Nov-13-19	Downgrade	Craig Hallum	Buy → Hold	$2.50
Nov-13-19	Downgrade	Canaccord Genuity	Buy → Hold	$2 → $1
Oct-23-19	Initiated	Stifel	Buy
Jul-05-19	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-29-19	Initiated	Piper Jaffray	Neutral

Show Previous Ratings

Jan-29-26 04:01PM	Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor (GlobeNewswire)
Jan-28-26 04:05PM	Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -7.21%
Jan-12-26 08:00AM	Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update (GlobeNewswire)
Jan-09-26 10:53AM	SENS Stock Up as Eversense 365 Enters AID Market With twiist System (Zacks)
Jan-08-26 04:01PM	Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist Automated Insulin Delivery (AID) System (GlobeNewswire) +8.04%
08:05AM	Loading…
Nov-10-25 08:05AM	Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire) +5.32%
08:00AM	Senseonics Announces Transfer to Nasdaq Stock Exchange (GlobeNewswire)
Nov-06-25 12:04AM	Senseonics Holdings Inc (SENS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) -7.58%
Nov-05-25 07:05PM	Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
06:03PM	Senseonics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports Third Quarter Financial Results (GlobeNewswire)
Nov-04-25 06:30PM	Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3 (Zacks)
08:36AM	What To Expect From Senseonics Holdings Inc (SENS) Q3 2025 Earnings (GuruFocus.com)
Oct-30-25 10:00AM	Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-29-25 10:00AM	Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
04:05PM	Loading…
Oct-22-25 04:05PM	Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time (GlobeNewswire) -9.17% +6.06%
Oct-21-25 11:27AM	Stifel resumes coverage on medtech names, sees long-term diabetes devices growth (Investing.com) -9.92%
Oct-06-25 04:05PM	Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update (GlobeNewswire) +22.03% -16.92%
Sep-03-25 05:17PM	Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 (GlobeNewswire)
Aug-21-25 09:55AM	Here's Why Senseonics (SENS) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Aug-06-25 06:10PM	Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:10PM	Senseonics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports Second Quarter Financial Results (GlobeNewswire)
Aug-05-25 10:18AM	What To Expect From Senseonics Holdings Inc (SENS) Q2 2025 Earnings (GuruFocus.com)
Jul-16-25 04:05PM	Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time (GlobeNewswire) +5.07%
Jun-25-25 07:59AM	Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength? (Zacks)
Jun-20-25 09:25AM	DXCM's Access Gains and Operational Strength Offset Margin Pressures (Zacks)
Jun-18-25 09:35AM	Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks (Zacks)
Jun-04-25 04:05PM	Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense 365 Continuous Glucose Monitoring System for People with Diabetes (GlobeNewswire)
May-21-25 05:06PM	Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement (GlobeNewswire) -5.57%
11:12PM	Loading…
May-15-25 11:12PM	Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement (GlobeNewswire) -5.11%
04:05PM	Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement (GlobeNewswire)
May-09-25 03:40AM	Senseonics Holdings Inc (SENS) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com) -15.17%
May-08-25 07:05PM	Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.78%
06:00PM	Senseonics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports First Quarter Financial Results (GlobeNewswire)
May-07-25 12:38PM	Senseonics Q1 2025 Earnings Preview (Seeking Alpha)
10:55AM	Senseonics Holdings Inc (SENS) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-30-25 11:13AM	Senseonics, Sequel partner to use 1-year CGM in automated insulin dosing system (MedTech Dive)
Apr-29-25 04:05PM	Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time (GlobeNewswire)
12:46PM	Sequel strikes deal with Senseonics for one-year CGM system (Medical Device Network)
07:30AM	Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM) (GlobeNewswire)
Apr-16-25 03:53PM	Is Senseonics Holdings (SENS) the Best Penny Stock to Invest in Under $1? (Insider Monkey)
Mar-06-25 12:00PM	Senseonics (SENS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -11.37%
Mar-04-25 02:04AM	Senseonics Holdings Inc (SENS) Q4 2024 Earnings Call Highlights: Eversense 365 Launch and ... (GuruFocus.com) -19.31%
Mar-03-25 05:15PM	Senseonics Holdings (SENS) Reports Q4 Loss (Zacks)
04:13PM	Senseonics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-28-25 07:12AM	What To Expect From Senseonics Holdings Inc (SENS) Q4 2024 Earnings (GuruFocus.com)
Feb-26-25 07:30AM	Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care (GlobeNewswire) +5.63%
Feb-13-25 04:05PM	Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire) +11.97% -5.34%
Feb-12-25 04:07PM	Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time (GlobeNewswire) +6.36%
Feb-07-25 12:28PM	Senseonics files for Eversense 365 CE Mark registration (Medical Device Network) +13.29%
Feb-06-25 04:05PM	Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor (GlobeNewswire)
Jan-22-25 07:47AM	Is Senseonics Holdings, Inc. (SENS) the Hottest Smid-Cap Stock So Far In 2025? (Insider Monkey) +8.25%
Jan-09-25 11:50AM	Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report (GuruFocus.com)
Jan-08-25 06:12PM	Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting (GlobeNewswire) -8.68% +80.62%
Jan-06-25 09:19AM	Heres Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10 (Insider Monkey) -6.22%
Dec-09-24 08:00AM	Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch (GlobeNewswire) +13.65%
Nov-12-24 08:00AM	Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 10:06AM	Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com) -12.53%
Nov-07-24 06:40PM	Senseonics Holdings (SENS) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.98%
05:34PM	Senseonics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:45AM	Earnings To Watch: Senseonics Holdings Inc (SENS) Reports Q3 2024 Result (GuruFocus.com)
Oct-25-24 08:00AM	Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering (GlobeNewswire)
Oct-24-24 08:00AM	Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time (GlobeNewswire)
Oct-16-24 04:30PM	Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System (GlobeNewswire)
Oct-10-24 04:10PM	Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor (PR Newswire) +7.31%
Sep-18-24 04:12AM	Senseonics and Ascensia announce FDA approval for one-year CGM system (Medical Device Network) -5.81%
Sep-17-24 11:24AM	FDA Approves Glucose Monitor That Can Be Worn for a Year (Design & Development Today) +10.34%
07:48AM	Senseonics receives FDA clearance for one-year CGM (MedTech Dive)
07:00AM	Eversense 365 Receives FDA Clearance: The World's First One Year CGM (GlobeNewswire)
Sep-06-24 04:05PM	Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -9.41%
Aug-08-24 05:36PM	Senseonics: Q2 Earnings Snapshot (Associated Press Finance) -6.79%
04:05PM	Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results (Business Wire)
Aug-06-24 07:27AM	Ascensias new head of CGM talks plans for a 365-day sensor (MedTech Dive) +5.86%
Jul-25-24 04:05PM	Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time (Business Wire) -5.61%
Jun-25-24 02:51AM	Senseonics tips 365-day CGM to double 2025 sales (MedTech Dive)
Jun-13-24 04:05PM	Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Associations 84th Scientific Sessions (Business Wire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-29-24 04:05PM	Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference (Business Wire)
May-15-24 08:55AM	Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales (Zacks)
May-14-24 03:08AM	Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com) +10.29%
May-13-24 04:30PM	Senseonics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results (Business Wire)
04:04PM	Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management (Business Wire)
May-09-24 04:05PM	Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution (Business Wire)
May-02-24 08:05AM	Senseonics Holdings, Inc. to Participate in Upcoming Conferences (Business Wire) +12.02%
Apr-30-24 10:54PM	Senseonics gets FDA clearance to pair CGM implant with insulin pumps (MedTech Dive) +11.70% -5.03%
04:05PM	Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time (Business Wire)
07:00AM	Eversense® CGM System Receives iCGM Designation by the US FDA (Business Wire)
Mar-12-24 07:00AM	SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS (PR Newswire)
Mar-08-24 08:05AM	Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (Business Wire) +5.75%
Mar-06-24 08:05AM	Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference (Business Wire)
Mar-02-24 08:54AM	Senseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 05:59AM	Q4 2023 Senseonics Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -10.48%
Feb-29-24 06:30PM	Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:20PM	Senseonics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Steven Edelman	Director	Nov 10 '25	Buy	6.55	10,000	65,500	74,708	Nov 13 04:48 PM
ROEDER DOUGLAS A	Director	Nov 07 '25	Buy	5.83	15,000	87,450	99,727	Nov 10 07:40 AM
Sullivan Frederick T.	Chief Financial Officer	Nov 07 '25	Buy	5.88	5,415	31,840	157,028	Nov 10 07:40 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SENS

Senseonics Holdings Inc

Upgrade your FINVIZ experience